Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 486

1.

Reply.

Cardet JC, Jiang X, Lu Q, Gerard N, McIntire K, Boushey HA, Castro M, Chinchilli VM, Codispoti CD, Dyer AM, Holguin F, Kraft M, Lazarus S, Lemanske RF, Lugogo N, Mauger D, Moore WC, Moy J, Ortega VE, Peters SP, Smith LJ, Solway J, Sorkness CA, Sumino K, Wechsler ME, Wenzel S, Israel E; AsthmaNet Investigators.

J Allergy Clin Immunol. 2019 Jul 9. pii: S0091-6749(19)30751-1. doi: 10.1016/j.jaci.2019.05.029. [Epub ahead of print] No abstract available.

PMID:
31300279
2.

Additional Intestinal Mucosal Biopsy Sampling for Research is Safe During Pediatric Endoscopic Procedures.

Moran CJ, Noreck J, Winter HS, Li EX, Biller JA, Israel EJ, Kaplan JL.

Clin Gastroenterol Hepatol. 2019 Jul 4. pii: S1542-3565(19)30731-1. doi: 10.1016/j.cgh.2019.06.040. [Epub ahead of print] No abstract available.

PMID:
31279952
3.

Elevated extracellular maspin after mechanical compression in vitro or allergen challenges in vivo.

Kim SH, Mitchel JA, McGill M, Cremona TP, Baek JW, Kasahara DI, Anathy V, Israel E, Park JA.

J Allergy Clin Immunol. 2019 Jun 19. pii: S0091-6749(19)30801-2. doi: 10.1016/j.jaci.2019.06.006. [Epub ahead of print]

PMID:
31228474
4.

Performance of Surveillance MR Enterography (MRE) in Asymptomatic Children and Adolescents With Crohn's Disease.

Chu KF, Moran CJ, Wu K, Kaplan JL, Savarino JR, Board T, Israel EJ, Winter HS, Gee MS.

J Magn Reson Imaging. 2019 May 30. doi: 10.1002/jmri.26811. [Epub ahead of print]

PMID:
31145502
5.

Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level.

Lazarus SC, Krishnan JA, King TS, Lang JE, Blake KV, Covar R, Lugogo N, Wenzel S, Chinchilli VM, Mauger DT, Dyer AM, Boushey HA, Fahy JV, Woodruff PG, Bacharier LB, Cabana MD, Cardet JC, Castro M, Chmiel J, Denlinger L, DiMango E, Fitzpatrick AM, Gentile D, Hastie A, Holguin F, Israel E, Jackson D, Kraft M, LaForce C, Lemanske RF Jr, Martinez FD, Moore W, Morgan WJ, Moy JN, Myers R, Peters SP, Phipatanakul W, Pongracic JA, Que L, Ross K, Smith L, Szefler SJ, Wechsler ME, Sorkness CA; National Heart, Lung, and Blood Institute AsthmaNet.

N Engl J Med. 2019 May 23;380(21):2009-2019. doi: 10.1056/NEJMoa1814917. Epub 2019 May 19.

PMID:
31112384
6.

Biologics, Clinical Context, and the Asthmas.

Casale TB, Israel E.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1437-1439. doi: 10.1016/j.jaip.2019.03.012. No abstract available.

PMID:
31076059
7.

Safety of enteral sildenafil in hemodynamically unstable children.

Bednarz AM, Israel EN, Beckman EJ, Johansen M, Thomas CA.

Cardiol Young. 2019 May;29(5):589-593. doi: 10.1017/S1047951119000209. Epub 2019 May 3.

PMID:
31046848
8.

Psyche Meets the Gatekeepers: Creating a More Humane Culture for Women in Medicine.

Flaherty SM, Misra M, Scott-Vernaglia SE, Taveras EM, Israel EJ.

Acad Med. 2019 Apr 16. doi: 10.1097/ACM.0000000000002766. [Epub ahead of print]

PMID:
30998579
9.

Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-Exacerbated Respiratory Disease: A Prospective Trial.

Cahill KN, Cui J, Kothari P, Murphy K, Raby BA, Singer J, Israel E, Boyce JA, Laidlaw TM.

Am J Respir Crit Care Med. 2019 Apr 12. doi: 10.1164/rccm.201809-1755OC. [Epub ahead of print]

PMID:
30978291
10.

Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma.

Lachowicz-Scroggins ME, Dunican EM, Charbit AR, Raymond W, Looney MR, Peters MC, Gordon ED, Woodruff PG, Lefrançais E, Phillips BR, Mauger DT, Comhair SA, Erzurum SC, Johansson MW, Jarjour NN, Coverstone AM, Castro M, Hastie AT, Bleecker ER, Fajt ML, Wenzel SE, Israel E, Levy BD, Fahy JV.

Am J Respir Crit Care Med. 2019 May 1;199(9):1076-1085. doi: 10.1164/rccm.201810-1869OC.

PMID:
30888839
11.

Reduction in pediatric gastroenterology ED visits can be sustained through physician accountability and financial incentives.

Kim J, Israel E, Rao S, Aaronson E, Weilburg J, Kaafarani H, Lee J.

Am J Emerg Med. 2019 Jun;37(6):1124-1127. doi: 10.1016/j.ajem.2019.03.011. Epub 2019 Mar 8.

PMID:
30876776
12.

Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate.

Cardet JC, Jiang X, Lu Q, Gerard N, McIntire K, Boushey HA, Castro M, Chinchilli VM, Codispoti CD, Dyer AM, Holguin F, Kraft M, Lazarus S, Lemanske RF, Lugogo N, Mauger D, Moore WC, Moy J, Ortega VE, Peters SP, Smith LJ, Solway J, Sorkness CA, Sumino K, Wechsler ME, Wenzel S, Israel E; AsthmaNet Investigators.

J Allergy Clin Immunol. 2019 Mar 11. pii: S0091-6749(19)30347-1. doi: 10.1016/j.jaci.2019.01.049. [Epub ahead of print]

PMID:
30872116
13.

What Patients Can Tell Us About Their Asthma.

Kankaanranta H, Israel E.

J Allergy Clin Immunol Pract. 2019 Mar;7(3):906-907. doi: 10.1016/j.jaip.2018.11.031. No abstract available.

PMID:
30832895
14.

Asthma and Corticosteroid Responses in Childhood and Adult Asthma.

Ramadan AA, Gaffin JM, Israel E, Phipatanakul W.

Clin Chest Med. 2019 Mar;40(1):163-177. doi: 10.1016/j.ccm.2018.10.010. Review.

PMID:
30691710
15.

Multiview Cluster Analysis Identifies Variable Corticosteroid Response Phenotypes in Severe Asthma.

Wu W, Bang S, Bleecker ER, Castro M, Denlinger L, Erzurum SC, Fahy JV, Fitzpatrick AM, Gaston BM, Hastie AT, Israel E, Jarjour NN, Levy BD, Mauger DT, Meyers DA, Moore WC, Peters M, Phillips BR, Phipatanakul W, Sorkness RL, Wenzel SE.

Am J Respir Crit Care Med. 2019 Jun 1;199(11):1358-1367. doi: 10.1164/rccm.201808-1543OC.

PMID:
30682261
16.

Challenges in assessing the efficacy of systemic corticosteroids for severe wheezing episodes in preschool children.

Guilbert TW, Bacharier LB, Mauger DT, Phipatanakul W, Szefler SJ, Boehmer S, Beigelman A, Fitzpatrick AM, Jackson DJ, Baxi SN, Benson M, Burnham CD, Cabana MD, Castro M, Chmiel JF, Covar R, Daines M, Gaffin JM, Gentile DA, Holguin F, Israel E, Kelly HW, Lazarus SC, Lemanske RF Jr, Ly N, Meade K, Morgan W, Moy J, Olin JT, Peters SP, Pongracic JA, Raissy HH, Ross K, Sheehan WJ, Sorkness C, Teague WG, Thyne S, Martinez FD; National Heart, Lung, and Blood Institute's AsthmaNet.

J Allergy Clin Immunol. 2019 May;143(5):1934-1937.e4. doi: 10.1016/j.jaci.2018.10.071. Epub 2019 Jan 17. No abstract available.

PMID:
30660645
17.

Racial disparities in asthma-related health care use in the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

Fitzpatrick AM, Gillespie SE, Mauger DT, Phillips BR, Bleecker ER, Israel E, Meyers DA, Moore WC, Sorkness RL, Wenzel SE, Bacharier LB, Castro M, Denlinger LC, Erzurum SC, Fahy JV, Gaston BM, Jarjour NN, Larkin A, Levy BD, Ly NP, Ortega VE, Peters SP, Phipatanakul W, Ramratnam S, Teague WG.

J Allergy Clin Immunol. 2019 Jun;143(6):2052-2061. doi: 10.1016/j.jaci.2018.11.022. Epub 2019 Jan 8.

PMID:
30635198
18.

Adapting clinical trial design to maintain meaningful outcomes during a multicenter asthma trial in the precision medicine era.

Sorkness CA, King TS, Dyer AM, Chinchilli VM, Mauger DT, Krishnan JA, Blake K, Castro M, Covar R, Israel E, Kraft M, Lang JE, Lugogo N, Peters SP, Wechsler ME, Wenzel SE, Lazarus SC; National Heart Lung and Blood Institute's “AsthmaNet”.

Contemp Clin Trials. 2019 Feb;77:98-103. doi: 10.1016/j.cct.2018.12.012. Epub 2018 Dec 27.

PMID:
30593883
19.

The asthma Symptom Free Days Questionnaire: how reliable are patient responses?

Yawn BP, Israel E, Wechsler ME, Pace W, Madison S, Manning B, Doros G, Fuhlbrigge A.

J Asthma. 2018 Oct 26:1-9. doi: 10.1080/02770903.2018.1531990. [Epub ahead of print]

PMID:
30365368
20.

Plasma tryptase elevation during aspirin-induced reactions in aspirin-exacerbated respiratory disease.

Cahill KN, Murphy K, Singer J, Israel E, Boyce JA, Laidlaw TM.

J Allergy Clin Immunol. 2019 Feb;143(2):799-803.e2. doi: 10.1016/j.jaci.2018.10.007. Epub 2018 Oct 16. No abstract available.

21.

Predictors of inhaled corticosteroid taper failure in adults with asthma.

Cardet JC, Codispoti CD, King TS, Bacharier L, Carr T, Castro M, Chinchilli V, Dunn R, Holquing F, Engle L, Nelson K, Ortega VE, Peters M, Ramratnam S, Krishnan JA, Wechsler ME, Israel E; National Heart, Lung, and Blood Institute Asthmanet.

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1335-1337.e3. doi: 10.1016/j.jaip.2018.05.039. Epub 2018 Sep 19. No abstract available.

22.

Development of a novel digital breath-activated inhaler: Initial particle size characterization and clinical testing.

Kesten S, Israel E, Li G, Mitchell J, Wise R, Stern T.

Pulm Pharmacol Ther. 2018 Dec;53:27-32. doi: 10.1016/j.pupt.2018.08.007. Epub 2018 Sep 7.

23.

Febrile Proteinuria in Hospitalized Children: Characterization of Urinary Proteins.

Gurevich E, Israel E, Segev Y, Landau D.

Front Pediatr. 2018 Aug 17;6:202. doi: 10.3389/fped.2018.00202. eCollection 2018.

24.

Neutrophil cytoplasts induce TH17 differentiation and skew inflammation toward neutrophilia in severe asthma.

Krishnamoorthy N, Douda DN, Brüggemann TR, Ricklefs I, Duvall MG, Abdulnour RE, Martinod K, Tavares L, Wang X, Cernadas M, Israel E, Mauger DT, Bleecker ER, Castro M, Erzurum SC, Gaston BM, Jarjour NN, Wenzel S, Dunican E, Fahy JV, Irimia D, Wagner DD, Levy BD; National Heart, Lung, and Blood Institute Severe Asthma Research Program-3 Investigators.

Sci Immunol. 2018 Aug 3;3(26). pii: eaao4747. doi: 10.1126/sciimmunol.aao4747.

PMID:
30076281
25.

Susceptibility to exacerbations in Black adults with asthma.

Grossman NL, Doros GD, Fandino N, Fuhlbrigge AL, Pace WD, Wechsler ME, Yawn BP, Israel E.

J Asthma. 2019 Jul;56(7):704-710. doi: 10.1080/02770903.2018.1486855. Epub 2018 Oct 4.

PMID:
29969928
26.

Association of free vitamin D3 concentrations and asthma treatment failures in the VIDA Trial.

Lima JJ, Castro M, King TS, Lang JE, Ortega VE, Peters SP, Denlinger LC, Israel E, Sorkness CA, Wechsler ME, Wenzel SE, Smith LJ.

Ann Allergy Asthma Immunol. 2018 Oct;121(4):444-450.e1. doi: 10.1016/j.anai.2018.06.001. Epub 2018 Jun 14.

27.

A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease.

Laidlaw TM, Cahill KN, Cardet JC, Murphy K, Cui J, Dioneda B, Kothari P, Raby BA, Israel E, Boyce JA.

J Allergy Clin Immunol. 2019 Jan;143(1):316-324.e7. doi: 10.1016/j.jaci.2018.06.001. Epub 2018 Jun 8.

PMID:
29890239
28.

Bacterial biogeography of adult airways in atopic asthma.

Durack J, Huang YJ, Nariya S, Christian LS, Ansel KM, Beigelman A, Castro M, Dyer AM, Israel E, Kraft M, Martin RJ, Mauger DT, Rosenberg SR, King TS, White SR, Denlinger LC, Holguin F, Lazarus SC, Lugogo N, Peters SP, Smith LJ, Wechsler ME, Lynch SV, Boushey HA; National Heart, Lung and Blood Institute’s “AsthmaNet”.

Microbiome. 2018 Jun 9;6(1):104. doi: 10.1186/s40168-018-0487-3.

29.

The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammation.

Nechama M, Kwon J, Wei S, Kyi AT, Welner RS, Ben-Dov IZ, Arredouani MS, Asara JM, Chen CH, Tsai CY, Nelson KF, Kobayashi KS, Israel E, Zhou XZ, Nicholson LK, Lu KP.

Nat Commun. 2018 Apr 23;9(1):1603. doi: 10.1038/s41467-018-03886-6.

30.

Pruning of the Pulmonary Vasculature in Asthma. The Severe Asthma Research Program (SARP) Cohort.

Ash SY, Rahaghi FN, Come CE, Ross JC, Colon AG, Cardet-Guisasola JC, Dunican EM, Bleecker ER, Castro M, Fahy JV, Fain SB, Gaston BM, Hoffman EA, Jarjour NN, Mauger DT, Wenzel SE, Levy BD, San Jose Estepar R, Israel E, Washko GR; SARP Investigators.

Am J Respir Crit Care Med. 2018 Jul 1;198(1):39-50. doi: 10.1164/rccm.201712-2426OC.

31.

Effects of endogenous sex hormones on lung function and symptom control in adolescents with asthma.

DeBoer MD, Phillips BR, Mauger DT, Zein J, Erzurum SC, Fitzpatrick AM, Gaston BM, Myers R, Ross KR, Chmiel J, Lee MJ, Fahy JV, Peters M, Ly NP, Wenzel SE, Fajt ML, Holguin F, Moore WC, Peters SP, Meyers D, Bleecker ER, Castro M, Coverstone AM, Bacharier LB, Jarjour NN, Sorkness RL, Ramratnam S, Irani AM, Israel E, Levy B, Phipatanakul W, Gaffin JM, Gerald Teague W.

BMC Pulm Med. 2018 Apr 10;18(1):58. doi: 10.1186/s12890-018-0612-x.

32.

ALX receptor ligands define a biochemical endotype for severe asthma.

Ricklefs I, Barkas I, Duvall MG, Cernadas M, Grossman NL, Israel E, Bleecker ER, Castro M, Erzurum SC, Fahy JV, Gaston BM, Denlinger LC, Mauger DT, Wenzel SE, Comhair SA, Coverstone AM, Fajt ML, Hastie AT, Johansson MW, Peters MC, Phillips BR, Levy BD; National Heart Lung and Blood Institute’s Severe Asthma Research Program- Investigators.

JCI Insight. 2018 Mar 22;3(6). pii: 120932. doi: 10.1172/jci.insight.120932. No abstract available.

33.

Asthma Step-Down Strategies: Perhaps the Patient Should Decide?

Lipworth B, Israel E.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):644-645. doi: 10.1016/j.jaip.2017.08.026. No abstract available.

PMID:
29524998
34.

Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids.

Peters MC, Kerr S, Dunican EM, Woodruff PG, Fajt ML, Levy BD, Israel E, Phillips BR, Mauger DT, Comhair SA, Erzurum SC, Johansson MW, Jarjour NN, Coverstone AM, Castro M, Hastie AT, Bleecker ER, Wenzel SE, Fahy JV; National Heart, Lung and Blood Institute Severe Asthma Research Program 3.

J Allergy Clin Immunol. 2019 Jan;143(1):104-113.e14. doi: 10.1016/j.jaci.2017.12.1009. Epub 2018 Mar 7.

PMID:
29524537
35.

Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations.

Jackson DJ, Bacharier LB, Mauger DT, Boehmer S, Beigelman A, Chmiel JF, Fitzpatrick AM, Gaffin JM, Morgan WJ, Peters SP, Phipatanakul W, Sheehan WJ, Cabana MD, Holguin F, Martinez FD, Pongracic JA, Baxi SN, Benson M, Blake K, Covar R, Gentile DA, Israel E, Krishnan JA, Kumar HV, Lang JE, Lazarus SC, Lima JJ, Long D, Ly N, Marbin J, Moy JN, Myers RE, Olin JT, Raissy HH, Robison RG, Ross K, Sorkness CA, Lemanske RF Jr; National Heart, Lung, and Blood Institute AsthmaNet.

N Engl J Med. 2018 Mar 8;378(10):891-901. doi: 10.1056/NEJMoa1710988. Epub 2018 Mar 3.

36.

Establishment of prophylactic enoxaparin dosing recommendations to achieve targeted anti-factor Xa concentrations in children with CHD.

Israel EN, Thomas CA, Mastropietro CW.

Cardiol Young. 2018 May;28(5):715-718. doi: 10.1017/S1047951118000173. Epub 2018 Mar 1.

PMID:
29490713
37.

Flexibility and strength training in asthma: A pilot study.

Olenich S, Waterworth G, Badger GJ, Levy B, Israel E, Langevin HM.

J Asthma. 2018 Dec;55(12):1376-1383. doi: 10.1080/02770903.2017.1414236. Epub 2018 Feb 8.

PMID:
29420095
38.

Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction.

Dunican EM, Elicker BM, Gierada DS, Nagle SK, Schiebler ML, Newell JD, Raymond WW, Lachowicz-Scroggins ME, Di Maio S, Hoffman EA, Castro M, Fain SB, Jarjour NN, Israel E, Levy BD, Erzurum SC, Wenzel SE, Meyers DA, Bleecker ER, Phillips BR, Mauger DT, Gordon ED, Woodruff PG, Peters MC, Fahy JV; National Heart Lung and Blood Institute (NHLBI) Severe Asthma Research Program (SARP).

J Clin Invest. 2018 Mar 1;128(3):997-1009. doi: 10.1172/JCI95693. Epub 2018 Feb 5.

39.

Food and Drug Administration-mandated Trials of Long-Acting β-Agonist Safety in Asthma. Bang for the Buck?

Suissa S, Israel E, Donohue J, Evans S, Kemp J.

Am J Respir Crit Care Med. 2018 Apr 15;197(8):987-990. doi: 10.1164/rccm.201709-1940PP. No abstract available.

PMID:
29357261
40.

Primary Cytomegalovirus Infection Causing Guillain-Barré Syndrome in a Living Renal Allograft Recipient.

Merzkani M, Israel E, Sachdeva M.

Case Rep Transplant. 2017;2017:7264793. doi: 10.1155/2017/7264793. Epub 2017 Nov 20.

41.

A functional splice variant associated with decreased asthma risk abolishes the ability of gasdermin B to induce epithelial cell pyroptosis.

Panganiban RA, Sun M, Dahlin A, Park HR, Kan M, Himes BE, Mitchel JA, Iribarren C, Jorgenson E, Randell SH, Israel E, Tantisira K, Shore S, Park JA, Weiss ST, Wu AC, Lu Q.

J Allergy Clin Immunol. 2018 Nov;142(5):1469-1478.e2. doi: 10.1016/j.jaci.2017.11.040. Epub 2018 Jan 9.

42.

Harmonizing the Nomenclature for Therapeutic Aerosol Particle Size: A Proposal.

Hillyer EV, Price DB, Chrystyn H, Martin RJ, Israel E, van Aalderen WMC, Papi A, Usmani OS, Roche N.

J Aerosol Med Pulm Drug Deliv. 2018 Apr;31(2):111-113. doi: 10.1089/jamp.2017.1396. Epub 2017 Nov 28. No abstract available.

43.

Anti-IgE or Anti-IL5: That Is the Question.

Israel E, Panettieri RA Jr.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):782-784. doi: 10.1016/j.jaip.2017.10.025. Epub 2017 Nov 14. Review. No abstract available.

PMID:
29150253
44.

Internet-Based Monitoring in the Severe Asthma Research Program Identifies a Subgroup of Patients With Labile Asthma Control.

Wong-McGrath K, Denlinger LC, Bleecker ER, Castro M, Gaston B, Israel E, Jarjour NN, Mauger DT, Peters S, Phillips BR, Wenzel SE, Fahy JV, Peters MC; National Heart Lung and Blood Institute’s Severe Asthma Research Program-3 Investigators.

Chest. 2018 Feb;153(2):378-386. doi: 10.1016/j.chest.2017.10.017. Epub 2017 Oct 26.

45.

Using Physician-Level Emergency Department Utilization Reports to Address Avoidable Visits by Patients Managed by Pediatric Specialists.

Lee J, Israel E, Weinstein H, Kinane TB, Pasternack M, Linov P, Kaafarani HMA, Greenspan P, Rao SK.

Hosp Pediatr. 2017 Nov;7(11):686-691. doi: 10.1542/hpeds.2017-0054.

46.

Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies.

Sonnappa S, McQueen B, Postma DS, Martin RJ, Roche N, Grigg J, Guilbert T, Gouder C, Pizzichini E, Niimi A, Phipatanakul W, Chisholm A, Dandurand RJ, Kaplan A, Israel E, Papi A, van Aalderen WMC, Usmani OS, Price DB.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):907-915.e7. doi: 10.1016/j.jaip.2017.07.032. Epub 2017 Sep 20.

47.

Severe and Difficult-to-Treat Asthma in Adults.

Israel E, Reddel HK.

N Engl J Med. 2017 Sep 7;377(10):965-976. doi: 10.1056/NEJMra1608969. Review. No abstract available.

PMID:
28877019
48.

Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age.

Teague WG, Phillips BR, Fahy JV, Wenzel SE, Fitzpatrick AM, Moore WC, Hastie AT, Bleecker ER, Meyers DA, Peters SP, Castro M, Coverstone AM, Bacharier LB, Ly NP, Peters MC, Denlinger LC, Ramratnam S, Sorkness RL, Gaston BM, Erzurum SC, Comhair SAA, Myers RE, Zein J, DeBoer MD, Irani AM, Israel E, Levy B, Cardet JC, Phipatanakul W, Gaffin JM, Holguin F, Fajt ML, Aujla SJ, Mauger DT, Jarjour NN.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):545-554.e4. doi: 10.1016/j.jaip.2017.05.032. Epub 2017 Aug 31.

49.

Novel Treatments for Airway Disease.

Cahill KN, Boyce JA, Israel E.

N Engl J Med. 2017 Aug 10;377(6):597. doi: 10.1056/NEJMc1708004. No abstract available.

PMID:
28813135
50.

Natural killer cell-mediated inflammation resolution is disabled in severe asthma.

Duvall MG, Barnig C, Cernadas M, Ricklefs I, Krishnamoorthy N, Grossman NL, Bhakta NR, Fahy JV, Bleecker ER, Castro M, Erzurum SC, Gaston BM, Jarjour NN, Mauger DT, Wenzel SE, Comhair SA, Coverstone AM, Fajt ML, Hastie AT, Johansson MW, Peters MC, Phillips BR, Israel E, Levy BD; National Heart, Lung, and Blood Institute’s Severe Asthma Research Program-3 Investigators.

Sci Immunol. 2017 Mar 10;2(9). pii: eaam5446. doi: 10.1126/sciimmunol.aam5446.

Supplemental Content

Loading ...
Support Center